Overview
IMACTIS is a privately held company specializing in medical equipment manufacturing, particularly in the realm of interventional radiology. Their key product, the Imactis® CT-Navigation™, is a technology designed to enhance the efficiency and accuracy of minimally invasive procedures through CT-assisted navigation. This enables healthcare professionals to perform precise interventions by providing real-time trajectory paths for needle placements and creating three-dimensional models of a patient’s anatomy.
Company Details
- Founded: 2009
- Founders: Stéphane Lavallée and Lionel Carrat
- Headquarters: Grenoble, France
- Company Size: 11-50 employees
- Industry Focus: Radiology, medical imaging, interventional oncology, image guidance, percutaneous interventions
- Website: [imactis.com](https://www.imactis.com/en/)
- Key Locations:
- 20, Rue du Tour de l'Eau, Grenoble, France
- 185 Alewife Brook Parkway Path, Suite 210, Cambridge, MA, USA
Recent Developments
In January 2023, IMACTIS was acquired by GE HealthCare, marking GE HealthCare’s first acquisition as an independent company. This acquisition emphasizes GE HealthCare's commitment to enhancing its CT interventional guidance capabilities. Pierre Olivier, the President and CEO of IMACTIS, noted that this acquisition allows for a strategic alignment that expands product reach by leveraging GE HealthCare’s established market access.
Product Offerings
- CT-Navigation™: Designed to improve the precision and speed of percutaneous interventions such as biopsies and tumor ablations. The system is implemented across leading healthcare facilities in Europe and the U.S., offering electromagnetic technology that provides real-time trajectory paths for needle placements.
Leadership
- Pierre Olivier: As President and CEO, he has been instrumental in navigating the company through its acquisition by GE HealthCare and in expanding its influence within the interventional radiology market.
- Lionel Carrat: Co-founder and Chief Technical Officer (CTO), instrumental in product development and technological advancements for the company.
Funding and Investment
IMACTIS has successfully completed Series A funding, raising approximately US$ 3.6 million with investment support from M Capital Partners and other stakeholders, all committed to fostering IMACTIS’s leading-edge solutions in medical technology.
Competitor Analysis
IMACTIS operates in a competitive environment alongside several key players in the interventional radiology sector:
- Insignia Medical Systems: Based in the UK, renowned for PACS and VNA solutions, presenting competitive enterprise imaging services.
- GE Healthcare: A leader in medical technology, expanding its capabilities with the acquisition of IMACTIS, thus enhancing its product offerings in imaging and diagnostics.
- Siemens Healthineers and Philips Healthcare: Major players offering comprehensive imaging solutions and technological innovations aimed at improving care services and reducing operational costs.
Technological Advancements
The CT-Navigation System by IMACTIS represents a significant advancement in medical technology, aiding medical professionals to conduct more accurate and safer image-guided interventions. The system's ability to display simulated real-time images aligns with the growing trend of precision healthcare solutions.
Strategic Implications
The acquisition by GE Healthcare positions IMACTIS technologies on a global platform, fostering improvements in diagnostic and therapeutic techniques. The competitive landscape is rapidly evolving, with companies like Siemens Healthineers, Philips, and GE leading innovations. Staying informed of these developments is crucial for stakeholders aiming to leverage cutting-edge solutions that address the increasing demand for precision in medical diagnostics and interventions.
